Literature DB >> 15670310

Profiling of differentially expressed genes in human uterine leiomyomas.

E-J Lee1, G Kong, S-H Lee, S B Rho, C-S Park, B-G Kim, D-S Bae, J J Kavanagh, J-H Lee.   

Abstract

Uterine leiomyomas are very common benign tumors resulting in clinically serious gynecological problems in women of reproductive age. Approximately, 1% of leiomyosarcoma was reported to arise in a preexisting leiomyoma. However, the molecular basis of these tumors is poorly understood. To understand the molecular changes during leiomyoma development, we profiled differentially expressed genes in ten paired leiomyoma and normal myometrial tissues using cDNA microarray chip analysis. We identified 67 genes (27 overexpressed and 40 underexpressed) which were scored as differentially expressed at least twofold in at least eight of ten patients. Eighteen of 67 genes have been already reported to be differentially expressed without their established functions in uterine leiomyoma and others have never been reported. Subsequently, the relative expression levels of representative genes from identified 67 genes were confirmed by reverse-transcriptase polymerase chain reaction and immunohistochemistry and were found to be consistent with the microarray data. This study could provide a new insight into the understanding of leiomyoma and leiomyosarcoma.

Entities:  

Mesh:

Year:  2005        PMID: 15670310     DOI: 10.1111/j.1048-891x.2005.15016.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  9 in total

Review 1.  A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays.

Authors:  Phyllis C Leppert; William H Catherino; James H Segars
Journal:  Am J Obstet Gynecol       Date:  2006-04-25       Impact factor: 8.661

2.  Fibroid-associated heavy menstrual bleeding: correlation between clinical features, Doppler ultrasound assessment of vasculature, and tissue gene expression profiles.

Authors:  Sophia E Tsiligiannis; Marina Zaitseva; Peter R Coombs; Paul Shekleton; Moshe Olshansky; Martha Hickey; Beverley Vollenhoven; Peter A W Rogers
Journal:  Reprod Sci       Date:  2012-09-20       Impact factor: 3.060

3.  Expression of p53 and p21(WAF-1), apoptosis, and proliferation of smooth muscle cells in normal myometrium during the menstrual cycle: implication of DNA damage and repair for leiomyoma development.

Authors:  Ayako Suzuki; Masatoshi Kariya; Noriomi Matsumura; Tsukasa Baba; Haruhiko Yagi; Masaki Mandai; Ikuo Konishi; Shingo Fujii
Journal:  Med Mol Morphol       Date:  2012-12-07       Impact factor: 2.309

4.  Gene expression profiling of multiple leiomyomata uteri and matched normal tissue from a single patient.

Authors:  Irina K Dimitrova; Jennifer K Richer; Michael C Rudolph; Nicole S Spoelstra; Elaine M Reno; Theresa M Medina; Andrew P Bradford
Journal:  Fertil Steril       Date:  2008-07-30       Impact factor: 7.329

5.  Phylogenetic modeling of heterogeneous gene-expression microarray data from cancerous specimens.

Authors:  Mones S Abu-Asab; Mohamed Chaouchi; Hakima Amri
Journal:  OMICS       Date:  2008-09

6.  Association of genetic variations in RTN4 3'-UTR with risk of uterine leiomyomas.

Authors:  Kui Zhang; Peng Bai; Shaoqing Shi; Bin Zhou; Yanyun Wang; Yaping Song; Li Rao; Lin Zhang
Journal:  Pathol Oncol Res       Date:  2013-03-12       Impact factor: 3.201

7.  Subtype-Specific Tumor-Associated Fibroblasts Contribute to the Pathogenesis of Uterine Leiomyoma.

Authors:  Xin Wu; Vanida A Serna; Justin Thomas; Wenan Qiang; Michael L Blumenfeld; Takeshi Kurita
Journal:  Cancer Res       Date:  2017-10-20       Impact factor: 12.701

8.  Absolute enrichment: gene set enrichment analysis for homeostatic systems.

Authors:  Vishal Saxena; Dennis Orgill; Isaac Kohane
Journal:  Nucleic Acids Res       Date:  2006-11-27       Impact factor: 16.971

9.  New Insights of Uterine Leiomyoma Pathogenesis: Endocannabinoid System.

Authors:  Thangesweran Ayakannu; Anthony H Taylor; Timothy H Marczylo; Justin C Konje
Journal:  Med Sci Monit Basic Res       Date:  2019-03-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.